Advertisement

 

doctorslounge.com

 
Powered by
Careerbuilder

 

                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS

   Newsletter

   Gastroenterology

   News

 

 Conferences


   CME

   Forum Archives

   Diseases

   Symptoms

   Labs

   Procedures

   Drugs

   Links

advertisement.gif (61x7 -- 0 bytes)

   Specialties

   Cardiology

   Dermatology

   Endocrinology

   Fertility

   Gastroenterology

   Gynecology

   Hematology

   Infections

   Nephrology

   Neurology

   Oncology

   Orthopedics

   Pediatrics

   Pharmacy

   Primary Care

   Psychiatry

   Pulmonology

   Rheumatology

   Surgery

   Urology

   Other Sections

   Membership

   Research Tools

   Medical Tutorials

   Medical Software

 

 

 

 Headlines:

 

 

 

Hepatitis B markers

"The two and half pairs"

This refers to the two pairs of markers (HBsAg and HBsAb, HBeAg and HBeAb) plus the HBcAb test (the half). The HBcAg will be totally degraded in the serum, it is not detectable in the serum.

When combined these tests are used to diagnose and evaluate HBV infection. In order to evaluate hepatitis markers the physician needs to address a series of questions:

1. Does the patient have HBV infection?

HBsAg (Hepatitis B surface Antigen)

  • Becomes positive in the serum within 2 to 6 months of the initial HBV infection
  • The first evidence of hepatitis B infection ( two to eight weeks before ALT and AST elevation)
  • Establishes infection with HBV
  • Implies infectivity
  • Persistence after acute illness denotes carrier state and may indicate chronic hepatitis infection.

2. Is the virus actively replicating?

HBeAg (Hepatitis Be Antigen)

  • Denotes viral replication and infectivity
  • Persistence 3 months after the acute phase suggests chronic infection

Infection caused by mutant forms of HBV leads to absence of HBeAg in serum. This is where HBV-DNA must be measured to determine infectivity.

3. Is the patient infective?

The presence of the antigens (HBsAg, HBeAg) in blood denotes infectivity. However, after the disappearance of HBsAg and before the appearance of HBsAb (which denotes cure), there is a window period (serological gap) in which the patient is still infective but there is no HBsAg in the blood. To detect infectivity during this period HBcAb (IgM) is used.

advertisement.gif (61x7 -- 0 bytes)
 

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application


HBcAb (IgM)

  • Detects infectivity during the serological gap.

HBeAb

  • Appears after HBcAb and implies decreasing infectivity

4. Is the patient cured?

Disappearance of HBsAg and appearance of HBsAb denotes recovery, noninfectivity and protection from recurrent HBV infection.

HBsAb

  • Denotes recovery from HBV or successful vaccination.

Persistence of the antigens (HBsAg, HBeAg) for 3 months after the acute phase of the disease suggests chronic hepatitis.

previous.gif (72x17 -- 347 bytes) next.gif (72x17 -- 277 bytes)
 

 advertisement.gif (61x7 -- 0 bytes)

 

 



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright © 2001-2007 The Doctors Lounge. All rights reserved.